Abacavir sulfate is a potent nucleoside reverse transcriptase inhibitor agent frequently administered in the management of human immunodeficiency virus (HIV) infection. It exerts its action by competitively inhibiting the process of the viral reverse transcriptase enzyme, thereby hampering the conversion of HIV RNA to DNA. This inhibition disrupts